CG Oncology, Inc. (CGON) Reports Q3 Loss of $0.57
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street slides as AI cash burn worries spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil prices set for fourth straight monthly gains as tanker attack highlights supply risks
Tweet
Share
E-mailGet Alerts CGON Hot Sheet
Join SI Premium – FREE
CG Oncology, Inc. (NASDAQ: CGON) reported Q3 EPS of ($0.57). Revenue for the quarter came in at $1.67 million versus the consensus estimate of $20 thousand.
For earnings history and earnings-related data on CG Oncology, Inc. (CGON) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel on FedEx Freight (FDXF): 'Enters Its Post-Breakup Era - Time to Hit the Gym and Focus on Itself'
- Dover raises tender offer cap to $300M, extends expiration date
- UniFirst Corp (UNF) Raises Quarterly Dividend 2.7% to $0.375; 0.6% Yield
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
